Abstract
Pain is a frequent and disabling symptom among multiple sclerosis (MS) and it is estimated to occur in 55% to 65% of patients. The mechanism of pain in MS has not yet been defined, because it can result from somatic, visceral, emotional, or neurologic impairment. The importance of this classification is related to different medical approaches to treat the pain in MS patients. In the management of symptomatic pain, new therapeutic strategies are now available to represent a great opportunity improving the quality of life. The availability of newer drugs for symptomatic treatment of pain in MS indicates a need to pay attention to this problem.
Keywords: Psychogenic Pain, Trigeminal neuralgia, Carbamazepine, Phenytoin, Lamotrigine, Tricyclic antidepressants, Cannabinoids
Current Clinical Pharmacology
Title: Drugs Treatment of Pain in Multiple Sclerosis
Volume: 2 Issue: 3
Author(s): Antonio Siniscalchi, Luca Gallelli and Giovambattista De Sarro
Affiliation:
Keywords: Psychogenic Pain, Trigeminal neuralgia, Carbamazepine, Phenytoin, Lamotrigine, Tricyclic antidepressants, Cannabinoids
Abstract: Pain is a frequent and disabling symptom among multiple sclerosis (MS) and it is estimated to occur in 55% to 65% of patients. The mechanism of pain in MS has not yet been defined, because it can result from somatic, visceral, emotional, or neurologic impairment. The importance of this classification is related to different medical approaches to treat the pain in MS patients. In the management of symptomatic pain, new therapeutic strategies are now available to represent a great opportunity improving the quality of life. The availability of newer drugs for symptomatic treatment of pain in MS indicates a need to pay attention to this problem.
Export Options
About this article
Cite this article as:
Siniscalchi Antonio, Gallelli Luca and De Sarro Giovambattista, Drugs Treatment of Pain in Multiple Sclerosis, Current Clinical Pharmacology 2007; 2 (3) . https://dx.doi.org/10.2174/157488407781668785
DOI https://dx.doi.org/10.2174/157488407781668785 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Molecular Methods for Individualization of Psychotropic Drug Treatment
Current Pharmacogenomics A Brief Overview on Chemistry and Biology of Benzoxepine
Letters in Drug Design & Discovery The Pivotal Role of Nitric Oxide: Effects on the Nervous and Immune Systems
Current Pharmaceutical Design The Clinical Problems of Hypertension Treatment in Hemodialysis Patients
Current Vascular Pharmacology Vasoactive Compounds in the Neonatal Period
Current Medicinal Chemistry Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) Annona sp: Plants with Multiple Applications as Alternative Medicine - A Review
Current Bioactive Compounds Beta-blockers in the Perioperative Period: Are there Indications other than Prevention of Cardiac Ischemia?
Current Drug Targets N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
Current Alzheimer Research Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Dissections of the Thoracic Aorta and Evolving Endovascular Strategies
Current Hypertension Reviews Extracellular Matrix Remodeling in Hypertension
Current Hypertension Reviews Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Current Vascular Pharmacology Adrenoceptors: Non Conventional Target for Breast Cancer?
Current Medicinal Chemistry The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Current Drug Targets Synthetic and Natural Coumarins as Cytotoxic Agents
Current Medicinal Chemistry - Anti-Cancer Agents